Sandoz, a division of Novartis, has halted the worldwide distribution of its generic version of Zantac, a popular heartburn medication. In a statement to Fox 11, Dana Kahn Cooper, a spokesperson for ...

All over-the-counter and prescription ranitidine medications-- commonly known by the brand name Zantac -- should be removed from the market “immediately,” the U.S. Food and Drug Administration (FDA) ...

The drug Zantac can elevate the risk of a person developing cancer. The active ingredient, ranitidine, contains a contaminant called NDMA, which is a probable human carcinogen. The above information ...

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...

People who took ranitidine (Zantac) for at least a month were no more likely to develop cancer than people who used other histamine-2 receptor antagonists (H2RAs), according to a retrospective ...